Robelet S - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Combination of acamprosate and baclofen as a promising therapeutic approach for Parkinson's disease.

Hajj R, Milet A, Toulorge D, Cholet N, Laffaire J, Foucquier J, Robelet S, Mitry R, Guedj M, Nabirotchkin S, Chumakov I, Cohen D. Hajj R, et al. Among authors: robelet s. Sci Rep. 2015 Nov 6;5:16084. doi: 10.1038/srep16084. Sci Rep. 2015. PMID: 26542636 Free PMC article.

Effect of the micro-immunotherapy medicine 2LPARK^® on rat primary dopaminergic neurons after 6-OHDA injury: oxidative stress and survival evaluation in an in vitro model of Parkinson's disease.

Lilli NL, Révy D, Robelet S, Lejeune B. Lilli NL, et al. Among authors: robelet s. Degener Neurol Neuromuscul Dis. 2019 Jul 8;9:79-88. doi: 10.2147/DNND.S202966. eCollection 2019. Degener Neurol Neuromuscul Dis. 2019. PMID: 31372089 Free PMC article.

Chronic L-DOPA treatment increases extracellular glutamate levels and GLT1 expression in the basal ganglia in a rat model of Parkinson's disease.

Robelet S, Melon C, Guillet B, Salin P, Kerkerian-Le Goff L. Robelet S, et al. Eur J Neurosci. 2004 Sep;20(5):1255-66. doi: 10.1111/j.1460-9568.2004.03591.x. Eur J Neurosci. 2004. PMID: 15341597

Influence of tachykinin NK2 receptors on intestinal sensitivity and motility in newborn rats.

Tramontana M, Evangelista S, Giuliani S, Manzini S, Robelet S, Girod V, Maggi CA. Tramontana M, et al. Among authors: robelet s. Neuropeptides. 2010 Jun;44(3):269-72. doi: 10.1016/j.npep.2010.01.002. Neuropeptides. 2010. PMID: 20137809

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4 results

Search Page

Filters